Treatment of BV With First Deqularum and Then Direkt After Clindamycin

Skaraborg Hospital

Status and phase: Unknown; Phase 3

Conditions: Infection, Bacterial

Treatments: Drug: treatment of BV with first Deqularum and then direkt after with vaginal clindamycin

Study type: Interventional

Funder types: Other

Identifiers

NCT04067531

12

Details and patient eligibility

About

Treatment of BV with first deqularum cloride and then followed with clindamycin vaginal Cream.

Full description

The hypoteses is that deqularum cloride takes away the biofilm so that clindamycin will kills the bacteria.

Cure rate will be followed up after 1 month and then after 6 month

Enrollment: 50 estimated patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• healthy women with BV

Exclusion criteria

• women treated with antibiotics within 1 month

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

treatment of BV

Other group

Description:

all patients be treated with first Deqularum then with clindamycin Cream,

Treatment:

Drug: treatment of BV with first Deqularum and then direkt after with vaginal clindamycin